Compounds > diptoindonesin g
Page last updated: 2024-11-13

diptoindonesin g

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

diptoindonesin G: from Hopea mengarawan; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Hopeagenus[no description available]DipterocarpaceaeA plant family of the order ERICALES.[MeSH]

Cross-References

ID SourceID
PubMed CID49857058
CHEMBL ID4079097
SCHEMBL ID19929836
MeSH IDM0539436

Synonyms (7)

Synonym
diptoindonesin g
SCHEMBL19929836
CHEMBL4079097
1190948-58-3
nsc788102
nsc-788102
AKOS040751603
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1443686Cytotoxicity against mouse P388 cells assessed as growth inhibition2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Synthesis and antitumor evaluation of 2,3-diarylbenzofuran derivatives on HeLa cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (8.33)29.6817
2010's7 (58.33)24.3611
2020's4 (33.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.30 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
10-hydroxycamptothecin
[no description available]		2.1510pyranoindolizinoquinoline
benzofurans
Benzofurans: Compounds that contain a BENZENE ring fused to a furan ring.		3.93110
resveratrol
trans-resveratrol : A resveratrol in which the double bond has E configuration.		2.0510resveratrolantioxidant;
phytoalexin;
plant metabolite;
quorum sensing inhibitor;
radical scavenger
stilbenes
Stilbenes: Organic compounds that contain 1,2-diphenylethylene as a functional group.. trans-stilbene : The trans-isomer of stilbene.		2.520stilbene
tamoxifen
[no description available]		2.2510stilbenoid;
tertiary amino compound		angiogenesis inhibitor;
antineoplastic agent;
bone density conservation agent;
EC 1.2.3.1 (aldehyde oxidase) inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
estrogen antagonist;
estrogen receptor antagonist;
estrogen receptor modulator
pauciflorol f
pauciflorol F: from the stem bark of Vatica pauciflora; structure in first source		7.1710
ConditionIndicatedRelationship StrengthStudiesTrials
Benign Neoplasms
[description not available]		02.1510
Neoplasms
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.		02.1510
Androgen-Independent Prostatic Cancer
[description not available]		02.4110
Prostatic Neoplasms, Castration-Resistant
Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.		02.4110
Breast Cancer
[description not available]		09.12110
Breast Neoplasms
Tumors or cancer of the human BREAST.		04.12110
Basal Cell Cancer
[description not available]		02.2510
Local Neoplasm Recurrence
[description not available]		02.2510
Acute Myelogenous Leukemia
[description not available]		02.1510
Leukemia, Myeloid, Acute
Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.		02.1510
Leukemia P388
An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.		02.0510